1. ltxguy6100
2. kkappel7947
3. drsillinois
4. mrskellydaniels
5. cfpalombo
1.bigbooter16 04/05/2018
Barclays cuts price target to $38 from $41
2.ltxguy6100 03/02/2018
Neofluidics Announces Collaboration with Pfizer Inc.
3.ltxguy6100 04/10/2018
Data Monitoring Committee for the Phase 3 ATLAS trial evaluating INLYTA as adjuvant therapy for patients at h…
4.kkappel7947 02/12/2018
FDA accepted and granted Priority Review
5.kkappel7947 01/24/2018
Wow News??? - BMO Capital sets PT at $39... a whole $2
6.jasonbennett387 07/09/2018
President Trump tweets criticism about Pfizers drug price increases
7.jasonbennett387 02/22/2018
Merck KGaA & and Pfizer receive Health Canada approval
8.kkappel7947 01/30/2018
Sees FY18 $2.90-3.00 vs $2.78
9.kkappel7947 01/25/2018
Johnson & Johnson has pulled out of the race to buy Pfizer's consumer health business, leaving GlaxoSmithKli…
10.ltxguy6100 01/26/2018
European regulators approved Pfizer and Merck's diabetes drug Steglatro
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW